Energy » Alternative Fuel | Amyris Inc.

Amyris Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
41,119.00
23,439.00
34,153.00
67,192.00
143,445.00
80,420
Cost of Goods Sold (COGS) incl. D&A
38,253.00
42,402.00
37,374.00
56,678.00
62,713.00
43,433
Gross Income
2,866.00
18,963.00
3,221.00
10,514.00
80,732.00
36,987
SG&A Expense
113,116.00
95,896.00
100,898.00
99,133.00
120,247.00
151,087
EBIT
110,250.00
114,859.00
-
88,619.00
39,515.00
114,100
Unusual Expense
121,706.00
128,822.00
24,545.00
29,904.00
3,263.00
56,359
Non Operating Income/Expense
5,147.00
20,171.00
1,423.00
695.00
4,776.00
1,622
Interest Expense
9,107.00
28,949.00
78,854.00
37,629.00
34,032.00
39,268
Pretax Income
235,754.00
5,572.00
213,400.00
96,781.00
72,034.00
211,349
Income Tax
847.00
495.00
468.00
553.00
295.00
-
Equity in Affiliates
-
2,910.00
4,184.00
-
-
-
Consolidated Net Income
234,907.00
2,167.00
221,877.00
97,334.00
72,329.00
211,349
Net Income
235,111.00
2,286.00
221,777.00
97,334.00
72,329.00
211,349
Net Income After Extraordinaries
235,111.00
2,286.00
221,777.00
97,334.00
72,329.00
211,349
Net Income Available to Common
235,111.00
2,286.00
221,777.00
97,334.00
93,369.00
212,606
EPS (Basic)
46.73
13.52
26.25
6.60
2.89
3.52
Basic Shares Outstanding
5,031.50
5,226.70
8,464.10
15,896.00
32,253.60
60,357.90
EPS (Diluted)
46.73
13.52
26.20
6.55
2.89
3.52
Diluted Shares Outstanding
5,031.50
8,124.00
8,464.10
17,643.00
32,253.60
60,357.90
EBITDA
93,611.00
99,890.00
95,922.00
77,245.00
28,157.00
109,177
Other Operating Expense
-
-
4,723.00
-
-
-
Non-Operating Interest Income
162.00
387.00
264.00
258.00
-
-
Minority Interest Expense
204.00
119.00
100.00
-
-
-
Other After Tax Income (Expense)
-
-
3,825.00
-
-
-
Preferred Dividends
-
-
-
-
21,040.00
1,257

About Amyris

View Profile
Address
5885 Hollis Street
Emeryville California 94608
United States
Employees -
Website http://www.amyris.com
Updated 07/08/2019
Amyris, Inc. is an industrial biotechnology company, which engages in the provision of bioscience solutions. It focuses on the research, development, manufacture, and sale of fuels and farnesene-derived products. Its products include cosmetics, flavors and fragrances, performance materials, diesel, jet fuel, and lubricants.